Opioid-induced Constipation

Last modified: September 23, 2013 01:04:08 PM

Approximately 41% of patients receiving opioids for moderate-to-severe pain experienced at least one event of constipation

Opioids, a class of pharmaceuticals that are prescribed for pain relief including morphine, codeine, OxyContin, Vicodin and others, have several negative side effects.  One of the more unpleasant of these side effects is constipation.

Constipation is the very infrequent passing of formed stools, or the hardening of stools that are difficult to pass.  There are several factors which can contribute to the onset of constipation, some of which are a lack of fiber, an inadequate intake of liquids, and a lack of exercise.  Constipation can also be caused by a variety of physical conditions and disease.  However, what often gets ignored is the fact that pain-relief medication based on opioids is also a major contributor to constipation.

Opioid medications in general affect the digestive system in a few ways.  First of all, the opioids slow the digestive system right down; stool simply takes much longer to get through.  The medications cause the small intestine to contract in a non-propulsive way, decreasing the longitudinal propulsive peristalsis which pushes food through the digestive tract.  The food ends up staying in one place.  Furthermore, opioids provoke gastroparesis, a partial paralysis of the stomach.  Food also ends up remaining in the stomach for a much longer period of time.  Digestive secretions are decreased with the ingestion of opioids, which means the urge or need to defecate will be greatly reduced.  It is thought that mu-opioid receptors present in the digestive system, spinal cord and brain are involved with causing constipation.

Symptoms of OIC include abdominal tenderness, hard and dry stools, difficulty and pain while defecating, bloating or bulging in the abdominal area, and a constant feeling of needing to use a toilet.  Other symptoms might include feeling tired, depressed, sick and having no appetite.  To treat OIC, physicians at first may simply recommend lifestyle changes such as a high-fiber diet and increasing water intake along with some exercise.  However, this may not work in all cases and may not even be viable for some patients, so other treatment may be necessary.  Most of the time, doctors will prescribe cathartics and/or laxatives at the same time the opioids are prescribed so that the patient will not suffer the distress of constipation.  The laxatives and cathartics will work to speed up the digestive process, increase intestinal motility and soften stool.

At times, oral medication may not work in the treatment of OIC; suppositories, enemas, rectal irrigation and manual evacuation may be necessary.  British doctors found that a combination therapy worked best for the treatment of OIC; medication and lifestyle changes were both beneficial when treating constipation.   However, some critics do say that the medication will not treat the underlying cause of OIC which is opioid receptor-mediated and needs specific, targeted treatment.  One treatment involves the use of methylnaltrexone, a mu-opioid receptor antagonist which counteracts the constipating effects of opioids without decreasing the opioid’s pain relief ability.

If an opioid medication has been prescribed by a doctor to combat pain, it is a patient’s right and duty to ask as many questions as possible in order to be informed and reduce the risk of developing OIC.

Opioid Receptors: How They Work

Last modified: September 23, 2013 01:03:25 PM

Opioid Receptors: How They Work

In the media, there is a lot of attention paid to prescription drugs like OxyContin and illegal substances like heroin, and the words opioids and opioid receptors get mentioned often.  However, in most cases these terms are not explained and the general public usually has no idea what opioids and opioid receptors are, and people usually don’t know why the opioids are so addictive.

First of all, opioids are semi-synthetic substances derived from the natural alkaloids found in the resin of the opium poppy.  An opiate, a term which is sometimes used as a synonym for opioid, is actually a subgroup within the opioid family.  Opioids are among the world’s oldest known drugs and their use predates the written word.

Opioid drugs, which include medications like Percocet, Vicodin and Oxycodone, alleviate pain all over the body by binding to the opioid receptors which are found in the spinal cord, the brain, and gastrointestinal tract.

What the opioid medications and illegal opioid drugs such as heroin do is interfere with the brain’s task of recognizing discomfort and pain once they get into the blood stream.  What makes these substances so highly addictive is their ability to stimulate the parts of the brain that deal with pleasurable and euphoric emotions; this is the “high” that some opioid users chase after.

There are four major types of opioid receptors; Nociception, delta, kappa, and mu.  All four can be found in the brain, but only mu receptors are found in the gastrointestinal tract and spinal cord as well as the brain.  Researchers believe that the mu receptor is the most important of the opioid receptors because it produces analgesia (pain suppression), reduced gastrointestinal function, respiratory depression, physical dependence and –most importantly for addicts – the feeling of euphoria.

When Opioids are used or abused for a long time, a tolerance for the drug gets developed, and the patient finds the need to ingest higher and higher doses to either achieve the characteristic “high” or pain-numbing effect.  This happens because of a process called endocytosis.  In endocytosis, the cell will internalize the opioid receptor, making far fewer opioid binding sites available on the surface of the cells to accept and receive the drugs.  With few receptors available, the dosage of opioid drugs will need to be ever increasing in order for the user to feel the same “high” or pain-relieving effects.

Withdrawal symptoms are intense and incredibly painful, causing intense suffering for the addict who is trying to kick the habit.  The pain is so terrible that many prefer to stay addicted to avoid the unpleasantness of withdrawal.  A person who is addicted and physically dependent on opioids should always seek professional medical help to deal with the withdrawal and resolve any underlying emotional or mental problems that can lead to a relapse in substance abuse behaviour.

What exactly are “Bath Salts”?

Last modified: September 23, 2013 12:57:28 PM

Synthetic cathinone(MDVP, MEphedrone) are marketed as "bath salts" to evade detection by authorities.

The innocuously named “Bath Salts” is actually very potent, highly addictive street drug which has had an enormous amount of media attention lately due to the psychotic and extremely violent behavior of some of those who use it.  Its euphemistic moniker came about due to the fact that the drug looks like regular, every day Epsom bath salts.

Bath salts usually contain MDPV, or methylenedioxypyrovalerone, and could also contain methylone or mephedrone, and are usually distributed in a powdered format that can be inhaled, smoked, or injected.  The synthetic drug’s composition can vary widely from batch to batch, making it incredibly difficult for those who need to give a user medical treatment.

MDPV produces an effect very much like that of amphetamines, and it speeds up the central nervous system.  Like amphetamines, there can also be powerful negative effects, like paranoia, hallucinations, and extremely violent behavior.  Other risks include cardiac arrest, kidney failure, and suicide due to psychosis.

This street concoction of MDPV, methylone and mephedrone, according to medical experts at hospitals and treatment centers, is one of the most addictive drugs in existence.  Dr. Heidi-Marie Farinholt of Aberdeen Hospital in Nova Scotia, Canada told CBC news about the drug’s additive qualities.

“It is extremely dangerous. So you take cocaine and multiply it by a factor of 10 and you have this.”

Other names for the drug range from the innocent-sounding ivory wave and vanilla sky to the more sinister monkey dust and hurricane Charlie.

The drug, frustratingly, is like other synthetic drugs in that it is very hard to detect.  It cannot be detected by drug-sniffing dogs or in urine samples.  Further making things difficult for law enforcement is the fact that the drug is almost always labelled as a common every day product, like insect repellent, window cleaner or simply bath salts.

What also makes the drug disturbing is that MDPV is not yet illegal; while methylone and mephedrone are illegal substances, MDPV, at least in Canada, will start to be classed as a schedule 1 substance under the Controlled Drugs and Substances act in the autumn of 2012.  This means it will be illegal and will be in the same category as heroin and cocaine.  In the US, the federal government is always playing a game of “catch-up” with the synthetic drug designers; when one synthetic drug becomes illegal, the manufacturers come up with another formulation to beat the law.

In summary, the drug “bath salts” is one of the most dangerous street drugs available:  it is highly addictive, it causes psychotic episodes, it is difficult to detect and for the moment, it enjoys a quasi-legal status.

Arizona Voters Say “Yes” to Medical Marijuana

Last modified: September 23, 2013 01:14:37 PM

Proposition 203, Medical marijuana legal in the state of Arizona

Arizona has become the most recent state to approve a measure that will allow people with certain conditions to get a prescription for medical marijuana. Fourteen other states, along with the District of Columbia, have such laws already on the books. The unofficial results of the Nov. 2 vote were posted on the website of the Arizona Secretary of State. Following the vote on Proposition 203, Arizona officials said the vote was too close to call. The state said “yes” votes represented 50.1 percent of the vote, while 49.8 percent said “no.” More than 1.6 million votes were cast and the measure passed by a narrow margin of about 4,341 votes.

The Arizona Department of Health Services will soon begin looking at who will be able to dispense medical marijuana and patient applications. Under the Arizona measure, medical doctors could recommend that certain patients be permitted to obtain the drug from designated and regulated outlets. Patients for whom marijuana may be recommended could suffer from conditions including cancer, HIV/AIDS, Alzheimer’s disease, glaucoma and Hepatitis C.

In addition to the District of Columbia, these states have approved similar propositions: Alaska, California, Colorado, Hawaii, Maine, Michigan, Montana, Nevada, New Jersey, New Mexico, Oregon, Rhode Island, Vermont and Washington. States have individual rules about the fees and allowable possession limits that will be imposed. Conditions for which medical marijuana may be prescribed also can vary by state.

Since 1972, marijuana has been regulated by the government. It’s considered a Schedule I Controlled Substance because it was said at the time it had no accepted medical purpose. Now that that’s changing, there are people on both sides, arguing why the drug should and shouldn’t be legal, even for medical use. Marijuana has long been blamed for providing a “gateway” to more serious drug use. Opponents of decriminalization for medical use say marijuana can also be addictive and that there are plenty of legal drugs available to help people with these conditions. Proponents of the measure argue that medical marijuana can be a safe and more effective treatment for people who are suffering painful diseases instead of opioids. They maintain that marijuana’s effects can help pain and other symptoms associated with certain conditions.

Opioid–Induced Neurotoxicity

Last modified: August 10, 2013 12:05:46 PM

Opioid-induced neurotoxicity

Opioid-induced neurotoxicity is when a drug based on the natural or synthetic alkaloid of the opium poppy (Papaver somniferum) becomes poisonous and starts to destroy or damage the nerve tissue of the person who has ingested it.  While neurotoxicity caused by opioid ingestion is rare, it can occur in palliative care situations or in situations where a person is taking prescribed medication for non-medicinal purposes.

Opioid-induced neurotoxicity can occur with any type of opioid; however, it is more likely to occur when the opioid used contains active metabolites which are created when the opioid is processed by the liver.  The kidneys then attempt to excrete the metabolites, but the metabolites may build up due to a decrease in kidney function or dehydration.

Opioid medications that contain these metabolites include meperedine, morphine, codeine, and hydromorphone.

While Oxycodone also contains metabolites, research at the present time has not been able to determine if its specific metabolites can provoke neurotoxicity.  Another common cause of neurotoxicity is a sudden increase in opioid medication to treat symptoms such as breathlessness or pain.

The onset of neurotoxicity can occur a few days after the start of opioid-based treatment or after increasing the medication dose to a level where metabolites can build up.  Things that can increase the likelihood of developing neurotoxicity are dehydration, drugs that work to depress the central nervous system, and infection of any sort.  Symptoms of opioid-induced neurotoxicity syndrome are varied and may occur individually or at the same time; oftentimes the symptoms may be misdiagnosed.  The symptoms can include:

  • Seizures, involuntary muscle twitching and spasms
  • Confusion, disorientation, hallucinations
  • Decrease in consciousness level
  • Hyperalgesia, or a painful reaction to non-painful stimuli
  • Pain becoming generalized all over the body
  • Drowsiness.

Treatment varies due to the cause of the opioid-induced neurotoxicity.  If dehydration is a contributing factor, then intravenous fluid should work to eliminate the neurotoxicity.  If the syndrome is caused by a decrease in kidney function, a reduction in the amount of opioid medicine will usually result in a reversal of the syndrome.  If neurotoxicity occurs because of a sudden, dramatic increase in opioid dosage, reducing the dose or rotating to a different opioid-based medication will resolve the neurotoxicity issue.

Basically, opioid neurotoxicity is managed by re-hydrating a patient and rotating medications:  a patient who had been receiving a regular opioid dose for more than two weeks and has not developed neurotoxicity is unlikely to develop it unless infection, dehydration or reduced kidney function occur.  Opioids should never be discontinued in the treatment of severe pain and shortness of breath, especially for patients in palliative care.